NCT04559685View on ClinicalTrials.gov

Study of Sonodynamic Therapy in Participants with Recurrent High-Grade Glioma

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 15, 2021

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2028

Conditions
High Grade Glioma
Interventions
COMBINATION_PRODUCT

SONALA-001(ALA) and MR-Guided Focused Ultrasound device (MRgFUS)

SONALA-001(ALA) given 5-7 hours prior to receiving the MRgFUS.

DEVICE

MR-Guided Focused Ultrasound device (MRgFUS)

MR-Guided Focused Ultrasound device (MRgFUS) alone

Trial Locations (1)

85013

RECRUITING

St. Joseph's Hospital and Medical Center, Phoenix

Sponsors

Collaborators (1)

InSightec
All Listed Sponsors
collaborator

Barrow Neurological Institute

OTHER

collaborator

Ivy Brain Tumor Center

OTHER

collaborator

SonALAsense, Inc.

INDUSTRY

collaborator

InSightec

INDUSTRY

lead

Nader Sanai

OTHER